by Case Western Reserve University Credit: Unsplash/CC0 Public DomainA new study by researchers at the Case Western Reserve School of Medicine reveals that a chemical used in the diabetes drug Ozempic and the weight-management drug Wegovy is not associated with an increased risk for suicidal thoughts. The findings about the chemical—known as semaglutide—are particularly significant because...
Year: <span>2024</span>
Anxiety attacks: Symptoms and calming techniques
by Kirstie Ganobsik Anxiety attacks can seem overwhelming when you’re in the middle of one, but with the right coping tools you can come out the other side. According to the Detroit Medical Center, an anxiety attack is a stretch of time during which you experience “intense” anxiety symptoms, especially fear. It can last anywhere...
Deep flaws in FDA oversight of medical devices, and patient harm, exposed in lawsuits and records
by Fred Schulte and Holly K. Hacker, KFF Health News Credit: Pixabay/CC0 Public DomainLiving with diabetes, Carlton “PeeWee” Gautney Jr. relied on a digital device about the size of a deck of playing cards to pump insulin into his bloodstream. The pump, manufactured by device maker Medtronic, connected plastic tubing to an insulin reservoir, which...
Overactive bladder not tied to sleep disturbance, fatigue or depression
by Lori Solomon Overall, patients with overactive bladder (OAB) do not have worse sleep disturbance, fatigue, or depression scores than the general population, according to a study published online Dec. 18 in Neurourology and Urodynamics. Sally Jensen, Ph.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues characterized sleep disturbance, depression, fatigue,...
Explainer-What Other Health Conditions Might Weight-loss Drugs Treat?
(Reuters) – Novo Nordisk’s blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways. Both treatments contain the active ingredient semaglutide, part of a class known as GLP-1 drugs that work by helping control blood sugar levels and triggering a feeling of fullness. New...
Two-step screening strategy could reduce diabetic heart failure
by UT Southwestern Medical Center Credit: Unsplash/CC0 Public DomainA two-step screening protocol that combines clinical risk assessment with biomarker testing can more effectively identify which patients with type 2 diabetes need medication to prevent heart failure, according to a study led by UT Southwestern Medical Center researchers. Published in Circulation, the study found that the new strategy...
Exercises to avoid with shoulder bursitis
People may develop shoulder bursitis due to repetitive overhead movements. Although doctors can often effectively treat the condition, some exercises may worsen it. Shoulder bursitis, also known as subacromial bursitis, is when the cushions between a person’s shoulder joint become inflamed and painful. These cushions are called bursae. Bursae are small, fluid-filled sacs located inside...
What to know about hemoglobin levels
Hemoglobin is an iron-rich protein in red blood cells that enables the blood to carry oxygen to tissues throughout the body. Low hemoglobin levels often indicate anemia, but high levels can also be a sign of a serious health condition. When someone has insufficient red blood cells or the ones they have do not work...
Why weight loss drugs stop working and how to break past the Ozempic plateau
After using Ozempic for a while, many people may reach a plateau with their weight loss progress. Jaap Arriens/NurPhoto via Getty ImagesDrugs such as Ozempic and Wegovy eventually reach a weight loss plateau, beyond which further weight loss slows or stops.Like any other healthy weight loss method, the body eventually settles at an appropriate weight,...
Newly discovered genetic mutation protects against Parkinson’s disease and offers hope for new therapies
by University of Southern California Credit: Unsplash/CC0 Public DomainA previously unidentified genetic mutation in a small protein provides significant protection against Parkinson’s disease and offers a new direction for exploring potential treatments, according to a new USC Leonard Davis School of Gerontology study. The variant, located in a mitochondrial microprotein dubbed SHLP2, was found to be...